- Home
- NDLS vs PMN Comparison
NDLS vs PMN Comparison
Compare NDLS & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDLS
- PMN
- Stock Information
- Founded
- NDLS 1995
- PMN 2004
- Country
- NDLS United States
- PMN Canada
- Employees
- NDLS N/A
- PMN N/A
- Industry
- NDLS Restaurants
- PMN Pharmaceuticals and Biotechnology
- Sector
- NDLS Consumer Discretionary
- PMN Health Care
- Exchange
- NDLS Nasdaq
- PMN Nasdaq
- Market Cap
- NDLS 29.8M
- PMN 23.5M
- IPO Year
- NDLS 2013
- PMN N/A
- Fundamental
- Price
- NDLS $0.71
- PMN $0.46
- Analyst Decision
- NDLS Buy
- PMN Strong Buy
- Analyst Count
- NDLS 2
- PMN 3
- Target Price
- NDLS $3.00
- PMN $4.33
- AVG Volume (30 Days)
- NDLS 2.0M
- PMN 848.0K
- Earning Date
- NDLS 11-05-2025
- PMN 11-13-2025
- Dividend Yield
- NDLS N/A
- PMN N/A
- EPS Growth
- NDLS N/A
- PMN N/A
- EPS
- NDLS N/A
- PMN N/A
- Revenue
- NDLS $494,752,000.00
- PMN N/A
- Revenue This Year
- NDLS $1.19
- PMN N/A
- Revenue Next Year
- NDLS N/A
- PMN N/A
- P/E Ratio
- NDLS N/A
- PMN N/A
- Revenue Growth
- NDLS N/A
- PMN N/A
- 52 Week Low
- NDLS $0.55
- PMN $0.38
- 52 Week High
- NDLS $1.74
- PMN $1.59
- Technical
- Relative Strength Index (RSI)
- NDLS 50.86
- PMN 48.51
- Support Level
- NDLS $0.67
- PMN $0.41
- Resistance Level
- NDLS $1.25
- PMN $0.46
- Average True Range (ATR)
- NDLS 0.11
- PMN 0.04
- MACD
- NDLS 0.01
- PMN -0.00
- Stochastic Oscillator
- NDLS 16.75
- PMN 30.61
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.